Valuation: DocMorris AG

Market Cap 482M 593M 514M 439M 827M 56.6B 840M 5.67B 2.22B 28.33B 2.23B 2.18B 94.52B P/E 2026 *
-6.09x
P/E 2027 * -12.2x
Enterprise Value 682M 839M 728M 622M 1.17B 80.1B 1.19B 8.03B 3.14B 40.1B 3.15B 3.08B 134B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.52x
Free-Float
65.15%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 2022-04-27
Director of Finance/CFO 56 2024-09-30
Chief Tech/Sci/R&D Officer - 2024-10-31
Director TitleAgeSince
Chairman 68 2022-04-27
Director/Board Member 53 2019-05-22
Director/Board Member 56 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 588M
+1.70%+0.41%-26.68%-22.43% 15.79B
-0.30%-8.17%-32.48%-37.57% 6.85B
+0.28%+2.14%-26.11%-15.60% 6.21B
0.00%+6.23%+0.67%-25.39% 4.32B
-0.78%-0.42%-20.88%-37.99% 3.33B
-1.10%-1.75%+3.82%-37.21% 3.06B
-2.35%-2.66%-43.22%-25.63% 3.05B
-0.29%-0.37%-14.91%+1.74% 2.63B
-0.31%-5.04%+70.03% - 2.44B
Average -0.31%-0.18%-9.97%-25.01% 5.3B
Weighted average by Cap. +0.25%-0.51%-18.05%-25.02%

Financials

2026 *2027 *
Net sales 1.24B 1.52B 1.32B 1.13B 2.12B 145B 2.16B 14.56B 5.69B 72.72B 5.71B 5.59B 243B 1.39B 1.71B 1.48B 1.27B 2.38B 163B 2.42B 16.35B 6.38B 81.66B 6.42B 6.28B 272B
Net income -81.01M -99.69M -86.41M -73.86M -139M -9.51B -141M -954M -372M -4.76B -374M -366M -15.89B -43.68M -53.75M -46.59M -39.82M -74.93M -5.13B -76.13M -514M -201M -2.57B -202M -197M -8.57B
Net Debt 200M 246M 213M 182M 343M 23.5B 349M 2.36B 920M 11.76B 924M 904M 39.24B 236M 290M 252M 215M 405M 27.71B 411M 2.78B 1.08B 13.87B 1.09B 1.07B 46.28B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
9.545CHF
Average target price
10.22CHF
Spread / Average Target
+7.06%

Quarterly revenue - Rate of surprise